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ABSTRACT It has been a signiﬁcant challenge to quantitatively study the dynamic intracellular processes in live cells. These
studies are essential for a thorough understanding of the underlying mechanisms regulating the signaling pathways and the
transitions between cell cycle stages. Our studies of Cdc20, an important mitotic checkpoint protein, throughout the cell cycle
demonstrate that ﬂuorescence correlation spectroscopy is a powerful tool for in vivo quantitative studies of dynamic intracellular
processes. In this study, Cdc20 is found to be present primarily in a large complex (.1 Mda) during interphase with a diffusion
constant of 1.8 6 0.1 mm2/s and a concentration of 76 6 24 nM, consistent with its association with the APC/C. During mitosis,
however, a proportion of Cdc20 dissociates from APC/C at a rate of 12 pM/s into a soluble pool with a diffusion constant of 19.5
6 5.0 mm2/s, whose size is most consistent with free Cdc20. This free pool accumulates to 50% of total Cdc20 (;40 nM) during
chronic activation of the mitotic checkpoint but disappears during mitotic exit at a rate of 31 pM/s. The observed changes in the
biochemical assembly states of Cdc20 closely correlate to the known temporal pattern of the activity of APC/CCdc20 in mitosis.
Photon counting histograms reveal that both complexes contain only a single molecule of Cdc20. The underlying mechanisms
of the activities of APC/CCdc20 throughout the cell cycle are discussed in light of our experimental observations.
INTRODUCTION
Cell cycle progression requires the ordered accumulation and
destruction of speciﬁc proteins, including the mitotic cyclins
that in turn control the activity of their associated cyclin-
dependent kinases (CDKs) (1,2). The anaphase-promoting
complex/cyclosome (APC/C) is a large, multi-protein com-
plex whose E3-ubiquitin ligase activity is precisely regulated
to ensure the timely ubiquitin-mediated proteolysis of cy-
clins and other key cell cycle regulators. During mitosis, the
APC/C is responsible for the irreversible segregation of
replicated chromatids to each daughter cell. This action is
delayed by the mitotic checkpoint (also known as the spindle
assembly checkpoint) until all chromosomes are attached
to spindle microtubules at the kinetochores. Central to the
checkpoint are the unattached kinetochores which generate a
‘‘wait anaphase’’ signal to prevent premature exit of mitosis
(3–6). Cdc20 is an essential activator of the APC/C through
its action as a substrate-speciﬁc adaptor protein that allows
recognition of a destruction box containing proteins by
the APC/C for ubiquitination (7,8). Inhibiting the ability of
Cdc20 to facilitate APC/C’s recognition of substrates such as
cyclin B and securin is therefore the primary function of the
mitotic checkpoint. For this, unattached kinetochores gen-
erate one or more Cdc20 inhibitors that selectively block
Cdc20-stimulated APC/C action on these substrates. Pro-
posed Cdc20 inhibitors include phosphorylation of Cdc20
itself by the mitotic kinase Bub1 (9), direct binding by oligo-
merizedMad2 (10) or BubR1 (11), or a four component com-
plex (namedMCC, for mitotic checkpoint complex) comprising
BubR1, Mad2, Bub3, and Cdc20 (12).
Although signiﬁcant progress has been made in under-
standing the mitotic checkpoint at the molecular level through
in vitro studies, much of the dynamic and kinetic information
in live cells that is crucial for developing a model for the
signaling pathway remains unknown. A key question is
whether Cdc20 serves as an essential, stoichiometric com-
ponent of the APC/C or as a kiss-and-run facilitator that
identiﬁes substrates, brings them to the APC/C, and then re-
leases to begin another cycle of substrate binding and recruit-
ment (13). Lack of a clear dynamic picture of the interaction
between the two proteins has led to two controversial models
on how the mitotic checkpoint regulates APC/CCdc20. The
ﬁrst model suggests that Cdc20 has a dynamic interaction
with the APC/C so that it allows Mad2, together with other
checkpoint proteins, to inhibit APC/C by sequestering its ac-
tivator Cdc20 (10,14). On the other hand, the second model
suggests that the previously proposed MCC, which contains
checkpoint proteins Mad2, BubR1, Cdc20, and Bub3, may
directly bind to and inhibit the APC/C, which has itself been
sensitized by unattached kinetochores (12,15). Similar ques-
tions also arise for APC/CCdc20 inhibition in interphase. Emi1
has been identiﬁed as an interphase inhibitor (16,17). How-
ever, it is not clear whether Emi1 binds and inhibits Cdc20
already associated with the APC/C or sequesters Cdc20 as it
dissociates from the APC/C (16).
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Understanding of the dynamic interactions between the
checkpoint proteins is important for establishing models that
explain the central question of the mitotic checkpoint, i.e.,
how the ‘‘wait anaphase’’ signal from a single unattached
kinetochore is transduced to halt the progression of the
mitosis (6,15,18). Deﬁnitive answers to these questions, like
many others arising from various cellular studies in cell bi-
ology, require quantitative understanding of the in vivo
dynamic intracellular processes in live cells. This poses
signiﬁcant challenges to the traditional biochemical exper-
imental methods and requires noninvasive in vivo and real
time quantitative measurements of the molecular concentra-
tions, the molecular diffusions, and the rates of reactions of
protein-protein interactions in live cells.
Fluorescence correlation spectroscopy (FCS) is a powerful
tool for studying the molecular dynamics of diffusion, rates
of biochemical reactions, as well as absolute concentrations
with single-molecule sensitivity (19,20). Recent develop-
ments in FCS have demonstrated its potential as a new,
enabling technology that allows noninvasive real time quan-
titative measurements of individual molecules in living cells
(21–27). In this study, we demonstrate that we can quantita-
tively monitor the evolution of the Cdc20-related biochem-
ical reaction processes in live cells with FCS. Throughout the
entire cell cycle, we measured the temporal dissociation of a
small Cdc20-containing species from a large Cdc20-contain-
ing complex (APC/CCdc20), the diffusion constants and ab-
solute concentrations of each Cdc20-containing species at
various stages of the cell cycle, the real time rates of the
reaction between the two Cdc20-containing complexes, and
the temporal degradation of the small Cdc20 species at the
exit of the mitosis. The underlying mechanisms of the ac-
tivities of APC/CCdc20 throughout the cell cycle are also
discussed in light of our experimental observations.
MATERIALS AND METHODS
Constructs and cell lines
Cells and methods of cell culture used in these studies were from established
sublines of the rat kangaroo Potorous tridactylus, PTK2. PTK2 cells and
derived lines were cultured in MEM-Earle’s supplemented with 10% fetal
bovine serum, sodium pyruvate, penicillin, and streptomycin. Cell lines
stably expressing ﬂuorescent protein fusions to human Cdc20 were gen-
erated by amphotropic retroviral infection (as described in Shah et al.(28)).
The cDNA for human Cdc20 was excised from a clone provided by Prof.
Peter Sorger (Massachusetts Institute of Technology, Cambridge, MA) and
ligated into the enhanced cyan ﬂuorescent protein (ECFP)-C1. This fusion
cDNA was ligated into the SnaBI/EcoRI sites of pBABEpuro, a retroviral
vector.
The retroviral plasmid containing the ﬂuorescent protein fusion was
cotransfected using the Fugene transfection reagent (Roche Pharmaceuti-
cals, Indianapolis, IN) into 293-GP cells (a human embryonic kidney cell
line harboring a portion of the Murine Moloney Leukemia Virus genome)
along with a VSV-G pseudotyping plasmid to generate amphotropic virus.
Forty-eight hours after transfection, the culture supernatant was collected,
ﬁltered, and mixed with 8 mg/mL hexadimethrine bromide (Polybrene,
Sigma, St. Louis, MO), and 10% of the total ﬁltrate was placed onto a
subconﬂuent culture (30–40%) of PTK2 cells in 35-mm dishes; 48 h after
infection, cells were split and replated in 10-cm dishes and subjected to
selection in 2 mg/mL puromycin for 14 days. High expressors (top 10%)
were cloned by ﬂuorescence-activated cell sorting (FACSVantage, Becton
Dickinson, San Jose, CA). Cells were maintained as polyclonal lines, with
cells expressing varying levels of ﬂuorescent protein fusion.
Instrumentation and measurements
Live cell images were taken on a modiﬁed Zeiss Axiovert inverted mi-
croscope using a 633 high numerical aperture (NA 1.4) Plan Apochromat
objective. Images were collected by a digital camera (C4742-95, Hama-
matsu, Hamamatsu City, Japan) and captured to a computer through the use
of AxioVision software (Carl Zeiss, Go¨ttingen, Germany).
For ﬂow cytometry analysis, cells from both control and ECFP-Cdc20
cell lines were ﬁxed in 50% ethanol for 20 min on ice before treating with
RNase at a ﬁnal concentration of 50 mg/ml. Propidium iodide was added to
the cell suspension at a ﬁnal concentration of 50 mg/ml for 15 min for cell
cycle measurement on BD FACS (Becton, Dickinson and Co., Franklin
Lakes, NJ).
FCS with two-photon excitation was performed on a modiﬁed Zeiss
Axiovert invertedmicroscope using one of the camera ports for FCSdetection
(Fig. 1 A and (26)). Brieﬂy, the collimated beam of a mode-locked tunable
Coherent (Palo Also, CA) Mira 900 Titanium-Sapphire laser with 76 MHz,
120 fs pulse width was coupled through a Zeiss 633 Plan Apochromat oil
immersion objective (NA ¼ 1.4). The ﬂuorescence from ECFP has an
emission peak at 477 nm and was collected with a backscattering geometry
and passed through a blue interference ﬁlter (HQ480/100M, Chroma Tech,
Brattleboro, VT). Photon counts were detected with a GaAsP photomultiplier
tube (PMT) detector (H7421-40, Hamamatsu). The detector signal was
correlated online by a Flex5000/FAST correlator (correlator.com). In the
PCH experiments, a Flex02-12D digital correlator was used to record the
photon counts with a dwell time of 50ms and ameasurement time of 30 s. The
recorded photon counts were stored and then analyzed with LFD Globals
Unlimited software (Champaign, IL). A detailed description of the FCS
experimental apparatus can be found elsewhere (26).
PTK2 cells were seeded into 35-mm coverslip-bottommicrowells (MatTek,
Ashwell, MA) in Phenol red-free culture medium. The cells were allowed to
adhere overnight at 37C in a 7.5% CO2 incubator. For nocodazole
experiments, cells were exposed to 300 nM nocodazole for 2–4 h. Cells in
mitosis were identiﬁed by phase contrast microscopy for FCSmeasurements.
During the FCS measurements, temperature on the sample stage was 30C,
controlled by an Air Stream Incubator (Nicholson Precision Instruments,
Bethesda, MD). The laser intensity was 1.80 mW at the sample to avoid
bleaching and photodamage to the cells. Autocorrelation curves measured
from cells were averages of 3–4 successive measurements, each 60-s long.
As described in our previous study (26), to evaluate the effect of
photobleaching of diffusing ECFP to our recovered diffusion constants, we
conducted several FCS measurements in solution with a laser power varying
from 1.5 to 5 mW and obtained virtually identical autocorrelation curves.
FCS measurements were then performed within a small volume inside the
cytosol of a cell with a laser power varying from 1.5 to 2.4 mW. Again we
obtained identical autocorrelation curves. The results of the control
experiments indicate that there is no detectable photobleaching of diffusing
ECFP within the range of incident laser intensity in our experiments.
Data analysis
Any dynamic process that affects the emission of ﬂuorescent molecules in a
solution causes ﬂuctuations in the ﬂuorescence signal F(t) that can be
characterized by a normalized autocorrelation function:
GðtÞ ¼ ÆdFð0ÞdFðtÞæ
ÆFðtÞæ2 ; (1)
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where FÆtæ is the ﬂuorescence obtained from the excitation volume at delay
time t, brackets denote ensemble average, and dF(t) ¼ F(t)  FÆtæ. The
ﬁtting formula is the standard ﬁt for the three-dimensional multi-component
diffusion:
GðtÞ ¼ +
i
1
Ni
11
t
td;i
 1
11
t
v
2
td:i
 12
; (2)
where Ni is the number of species i, td,i is the characteristic diffusion time
during which an ith species molecule resides in the excitation volume with
an axial (z0) to lateral (r0) dimension ratio v (¼ z0/r0), and td;I ¼ r20=8Di is
deﬁned as the average lateral diffusion time under two-photon excitation for
an ith species molecule with diffusion coefﬁcient Di through the excitation
volume. For a single diffusion species, the average number of moleculesN¼
g/G(0), with g of 0.076 (29). Thus the number of photons per molecule per
second h (i.e., molecular brightness) can be calculated from the average
detected ﬂuorescence intensity with the average number of molecules in the
excitation volume. In the presence of the cellular background, the measured
correlation function amplitude must be scaled by ÆF(t)æ2/[ÆF(t)æ  ÆFBGæ]2,
where ÆFBGæ is the time-averaged background signal obtained from exper-
iments on nontransfected cells as a control (26,30).
To calculate the rates of changes in the concentration of measured spe-
cies within mitosis, we recorded the average time span that each phase takes
(Fig. 1 D). The rate of changes in concentration is calculated based on the
time span of the phases of interest and the corresponding changes in the
concentration.
In the case of multiple diffusion species, a photon-counting histogram
(PCH) is applied to recover the molecular brightness hi of each species (31).
This method analyzes the probability distribution of the photon counts that is
experimentally determined by the PCH, which has the sensitivity to resolve a
mixture of monomers and dimers. In practice, PCH represents the prob-
ability to detect k photons per sampling time. The probability p(k) to detect k
photons from a single diffusing molecule is a weighted average of Poisson
distributions, each with the mean value eI(r):
pðkÞ ¼
Z ½eIðrÞkexp½eIðrÞ
k!
qðrÞdr; (3)
where I(r) is the point spread function normalized at the origin and q(r) is the
probability to ﬁnd the molecule at the position r. To generalize this equation
for N diffusing molecules, I(r) and q(r) must be replaced by +N
i¼1IðrÞ, andQN
i¼1 qðrÞ, respectively, and the integration is performed over the 3N coor-
dinates of the molecules. Finally, to determine the PCH for an open two-
photon excitation volume with a ﬂuctuating number of molecules inside,
p(k) is averaged with a Poisson distribution n(N) for the number of mol-
ecules:
FIGURE 1 (A) Experimental setup for two-photon FCS
measurements. (B) Flow cytometry cell cycle analysis of
the control PTK2 cells and ECFP-Cdc20 expressing
PTK2 cells. (C) ECFP-Cdc20 expressing PTK2 cell un-
dergoing mitosis. (D) Average lengths of each phase in
mitotic ECFP-Cdc20 expressing PTK2 cells versus that
in the control PTK2 cells.
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Y
ðkÞ ¼ +
N
N¼0
pðkÞnðNÞ: (4)
RESULTS
FCS measurements were conducted within the cytoplasm of
interphase and mitotic cells. FCS is able to resolve a mixture
of ﬂuorescent species by differences in their diffusion con-
stant especially when the molecular mass between the two
species differs more than a factor of 5–8 (32). Therefore,
diffusion of the free ECFP-Cdc20 fusion (;85 kDa) is ex-
pected to be much faster than when it is bound to the APC/C
(;1,600 kDa). In addition, the molecular brightness h,
another important parameter of the ECFP-Cdc20 fusion, can
be determined by FCS and a related technique, PCH (24,31),
and allows the determination of the number of Cdc20 mol-
ecules per diffusing complex. The knowledge of this is im-
portant because, although Cdc20 has been found in the
APC/C immunoprecipitates, it has not been quantitatively
identiﬁed as a stoichiometric component in the APC/C
puriﬁcations (3).
Lines of PtK2 cells were generated using amphotropic
retroviruses to stably introduce a gene encoding ECFP fused
in frame with Cdc20. Consistent with previous observations,
ECFP-Cdc20 was localized to the cytoplasm and the cen-
trosome of interphase cells (33). As expected from the
intermolecular associations of other GFP-Cdc20 fusions that
have been shown to retain the functional associations with
endogenous partners (33,34), the resulting cells displayed
normal cell cycles, advancing through interphase and each
step in mitosis with timings that were indistinguishable from
the initial cells (Fig. 1, B–D).
Cdc20 is a component of a stable megadalton
complex in interphase
Thirteen interphase cells were followed, and FCS measure-
ments were sequentially made on each until it entered mito-
sis. Autocorrelation functions obtained from cells that entered
mitosis within 2 h after FCS measurements were considered
to be from cells in the G2 phase of the cell cycle. Other
autocorrelation functions obtained between 15 and 6 h before
the cells entered mitosis were considered from late G1, S
phase or early G2 phase cells, respectively. FCS measure-
ments were also conducted on cells known to be in early G1
since they were made in cells immediately after the ab-
scission of two daughter cells. In all of these interphase cells,
Cdc20 behavior could be well modeled by a single three-
dimensional diffusion species model. An average cytoplas-
mic concentration of 76 6 24 nM was recovered from this
analysis, similar to the 100-nM level measured with
quantitative immunoblotting for endogenous Cdc20 (11).
In addition, an average diffusion constant of 1.86 0.1 mm2/s
(Fig. 2) was also obtained which indicates that, in interphase
cells, most Cdc20 is stably associated with a large complex.
The intracellular diffusion constant of free ECFP (;30 kDa)
was determined to be 21mm2/s (26). Whereas other FCSmea-
surements have identiﬁed complexes in the million dalton
(MD) range to have a diffusion constant of 3.2 mm2/s (27),
the small 1.8 mm2/s diffusion constant for the ECFP-Cdc20
must indicate that throughout interphase most Cdc20 is
found in a large complex with a molecular mass in the range
of .1 MDa. Since the APC/C is a high molecular mass
complex composed of at least 11 subunits whose molecular
mass is estimated to be;1.5 MDa (12) and previous studies
have demonstrated that Cdc20 binds to interphase APC/C
both in vivo and in vitro (10,11), this large Cdc20-containing
complex observed in interphase is consistent with its asso-
ciation with a complex containing APC/C, which we will
hereinafter refer to as APC/CCdc20.
A smaller complex of Cdc20 accumulates early in
mitosis and is lost after telophase
FCS measurements were conducted on individual mitotic
cells (n ¼ 14) as mitosis progressed. The laser beam was
FIGURE 2 (A) ECFP-Cdc20 expressing PTK2 cell in early G1 phase. (B)
ECFP-Cdc20 expressing PTK2 cell in interphase. (C) The autocorrelation
functions from the FCS measurements on interphase cells (G2 and early G1
phase) are ﬁtted with a single species model (bold solid lines), which reveals
that Cdc20 is a stable component of a large complex in interphase cells with
a diffusion constant of D ¼ 1.8 6 0.1 mm2/s.
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positioned at randomly selected locations in the cytoplasm
to avoid chromosomes. In prophase (Fig. 3 A) (before
nuclear envelop breakdown), the measured autocorrelation
functions were still well ﬁtted by a single species model
with an identical diffusion constant to that of interphase
cells (;1.8 mm2/s) (Fig. 3 G), indicating most or all Cdc20
stays associated with a .1 MDa complex consistent with
APC/CCdc20. However, as mitosis proceeded beginning
with nuclear envelope breakdown (Fig. 3, B–E), the auto-
correlation functions exhibited a faster decay (Fig. 3 H),
indicating the emergence of a signiﬁcantly faster diffusing
component.
The autocorrelation functions obtained between prophase
and cytokinesis could not be ﬁtted with a single species
model. A two species model, however, provided an excellent
ﬁt to the experimental evidence (Fig. 3 H), with the ﬁrst
species (D1) with a diffusion constant of 19.5 6 5.0 mm2/s.
As before, a larger complex (D2) was also present with a
diffusion constant (1.7 6 0.2 mm2/s) indistinguishable
from the large APC/CCdc20 complex seen in interphase. The
abundance of the larger complex D2 decreased steadily from
prophase to metaphase and then remained at that level from
anaphase to cytokinesis (Fig. 4 A). The smaller complex, D1,
was essentially absent during interphase, but gradually in-
creased at a rate of 12 pM/s after nuclear envelope break-
down, reaching a maximum in late prometaphase, when it
was ;½ of total Cdc20 (Fig. 4, B and C).
Constant ﬂuorescence intensity demonstrated that Cdc20
levels were stable from prophase until late prometaphase
(Fig. 4 D), indicating that the smaller D1 complex may result
from Cdc20 dissociating from the large APC/CCdc20 com-
plex. At late prometaphase/metaphase, however, the ﬂuo-
rescence intensity of ECFP-Cdc20 decreased, reaching a
level by cytokinesis that was only half that in early mitosis
(Fig. 4D). This loss was not due to repetitive photobleaching
since ﬂuorescence intensity recorded with a 2-s measure-
ment time (compared to 3–4 min for a FCS measurement) in
prophase followed by a second measurement at anaphase or
telophase revealed the same changes (data not shown). The
small complex D1 progressively decreased at a rate of 31
pM/s, becoming undetectable by cytokinesis (Fig. 4, B and
C), as manifested by the continuous loss of the fast decay
component in the autocorrelation functions until cytokinesis,
where the autocorrelation curves were again well ﬁtted with
a single species model with a diffusion constant ;1.8 mm2/s
(Fig. 3, G and H). Previous real time imaging had reported
Cdc20 proteolysis during mitotic exit (33); our evidence
reveals that it is the small (D1) species that is exclusively lost
after anaphase onset.
To determine the abundances of the two Cdc20 complexes
during maximally activated mitotic checkpoint signaling,
microtubules in mitotic cells (n ¼ 4) were disassembled by
treatment with nocodazole for 2–4 h, a time sufﬁcient for
complete APC/CCdc20-mediated degradation of cyclin A (2–4
times the length required for these cells to normally enter and
complete mitosis, as shown in Fig. 1 D). FCS measure-
ments on these cells revealed a signiﬁcant amount (;25 nM)
of the APC/C-free D1 complex of Cdc20 (16 6 6 mm2/s)
(Fig. 4 B).
FIGURE 3 (A) ECFP-Cdc20 cell in prophase. (B) ECFP-Cdc20 cell in
prometaphase. (C) ECFP-Cdc20 cell in metaphase. (D) ECFP-Cdc20 cell
in anaphase. (E) ECFP-Cdc20 cell in telophase. (F) ECFP-Cdc20 cell in
cytokinesis. (G) The autocorrelation functions from the prophase and the
cytokinesis phases ofmitotic cells indicate that Cdc20 stays bound to the large
complex at the beginning and the end of the mitosis, respectively. (H) FCS
measurements demonstrate a prominent faster decay of the autocorrelation
functions from the onset of prometaphase as a result of the emergence of a
faster diffusion component. The autocorrelation functions need to be ﬁtted
with a two species model with D1 (D¼ 19.56 5.1 mm2/s) and D2, the large
complex already observed in interphase (D¼ 1.76 0.2mm2/s). Starting from
the transition between late prometaphase and metaphase, the decay of the
autocorrelation functions reverses and continually slows down until cytoki-
nesis, where the autocorrelation functions can be adequately analyzed by a
single species model. The gray solid lines show a single species model ﬁt for
prophase and cytokinesis, and the colored bold solid lines represent a two
species model for other phases in mitosis.
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Only one ECFP-Cdc20 exists in each
Cdc20-containing complex throughout the
cell cycle
Recent studies have demonstrated that analysis of the molec-
ular brightness h (number of photons emitted per molecule
per second) can identify the oligomerization state of proteins
(24,26,27). This is because a dimer appears twice as bright as
the monomer so that the molecular brightness of a dimer will
be twice that of a monomer.
The molecular brightness h of ECFP-Cdc20 in interphase
cells was determined to be 3500 6 400 cpsm, essentially
indistinguishable from our previous determination for mon-
omeric ECFP (3400 6 100 cpsm) (26). Since each Cdc20
protein is genetically tagged with one ECFP molecule, this
indicates that each large complex in interphase carries only
one ECFP-Cdc20.
For mitotic cells in which the autocorrelation functions
could only be ﬁttedwith a two speciesmodel, the amplitude of
an autocorrelation curve G(0) does not have the simple re-
lationship to the number of diffusing molecules as it does in a
single species model (29). To recover the molecular bright-
ness of D1 and D2, we used a related technology-PCH (31).
PCH measurements were conducted ﬁrst on nontransfected
control cells to evaluate the effects of autoﬂuorescence of the
cells. PCH analysis yielded a molecular brightness of 270 6
30 cpsm and 76 2 autoﬂuorescent molecules in the excitation
volume. The PCH measurements were then conducted on
ECFP-Cdc20 cells at each mitotic stage. For the determina-
tion of the molecular brightness of D1 and D2, autoﬂuor-
escence was accounted for by including the autoﬂuorescent
molecules in the PCH analysis using the average molecular
brightness and number of autoﬂuorescent molecules obtained
from uninfected control cells. Although the proportions of the
large and small complexes vary signiﬁcantly at different mi-
totic stages (Fig. 4, A and B), this analysis recovered a single
molecular brightness value of 3400 6 600 cpsm throughout
the mitosis (Fig. 5). Therefore, the transient small complex
(D1) and the APC/CCdc20 (D2) complex present throughout
the cell cycle contain a single molecule of Cdc20.
DISCUSSION
In this study, we demonstrated that FCS is an important tool
for quantitative investigations of in vivo dynamic intracel-
lular processes via the real time observation of the evolution
of the biochemical assembly states of Cdc20 throughout the
entire cell cycle. We found that Cdc20 is stoichiometrically
FIGURE 4 Concentration of Cdc20 complexes is calculated based on the
calibrated excitation volume of our system (26) and Ni obtained through the
analysis of autocorrelation functions with Eq. 2. (A) Concentration of large
Cdc20 complex (D2) across the cell cycle. (B) Concentration of small Cdc20
complex (D1) across the cell cycle. (C) The changes in the total concentration
ofCdc20 across the cell cycle. The solid line represents the temporal pattern of
APC/CCdc20 activities described in previous review (4). (D) The ﬂuorescence
intensity was monitored during the FCSmeasurements. It shows that in early
mitosis the ﬂuorescence intensity is stable, indicating a stable abundance of
Cdc20 in the cells. The decrease in the intensity from late prometaphase
reﬂects the degradation of Cdc20 during the mitotic exit.
FIGURE 5 PCH of mitotic ECFP-Cdc20 cells. The symbols represent the
experimental data; the solid line shows ﬁts with a single component model,
indicating that there is a single molecular brightness for ECFP-Cdc20
regardless of the ECFP-Cdc20 complex.
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complexed to form APC/CCdc20 throughout interphase with a
diffusion constant of 1.86 0.1 mm2/s and a concentration of
76 6 24 nM. After mitotic entry, as much as half of all
Cdc20 is released into a much smaller complex (or com-
plexes) at a rate of 12 pM/s, which peaks at metaphase (;40
nM) before quantitative loss by telophase at a rate of 31 3
103 nM/s. This APC/C-free Cdc20 has a much faster
diffusion constant (19.56 5.0 mm2/s), consistent with either
free monomeric Cdc20 or a small Cdc20-containing com-
plex. Both APC/CCdc20 and the small Cdc20 species contain
only a single molecule of Cdc20. The emergence of the
smaller species cannot result from photodynamic ﬂickering,
a phenomenon in which a faster decay component emerges
relative to molecular diffusion due to the proton displace-
ment inside the molecular structure, because ECFP does not
exhibit such proton-driven ﬂickering (26). The quantitative
information of the dynamic behavior of the Cdc20 species
obtained in this study provides signiﬁcant insights into the
underlying mechanisms regulating the activity of APC/
CCdc20 throughout the cell cycle.
Inhibition of interphase APC/CCdc20 complex
Our FCS measurements have demonstrated that interphase
Cdc20 is in a megadalton complex consistent to the APC/
CCdc20. Recent work has identiﬁed Emi1/Rcal as a protein that
inhibits APC/CCdc20 in interphase (16,17,35,36). However,
how Emi1 inhibits APC/CCdc20 in interphase is not well
understood. Fractionation experiments have shown separate
Emi1-Cdc20 and APC/CCdc20 complexes in egg extracts,
suggesting a model in which Cdc20 is sequestered away from
the APC/C by Emi1 (16). On the other hand, exogenously
added Emi1 can inhibit the APC/C already associated with
Cdc20 in mitotic egg extracts, leading to a direct inhibition
model (16). The molecular mass of free ECFP-Cdc20 and
ECFP-Cdc20-Emi1 is 85 kDa and 135 kDa, respectively,
whereas the mass of APC/C is ;1.5 MD. If the interaction
between Cdc20 and APC/C is dynamic to produce a
signiﬁcant steady-state concentration of Cdc20 unbound to
APC/C, a much faster and smaller component should have
been detected in our analysis of the autocorrelation functions
in view of the signiﬁcant difference in mass between APC/
CCdc20 and free Cdc20 or Cdc20-Emi1. Our evidence in
interphase indicates that most of the Cdc20 is associated with
APC/C to form APC/CCdc20 in interphase. Considering the
possibility that small Cdc20 complexes could be present in
interphase at concentrations below the detection limit of FCS,
we conclude that Emi1 acting primarily by directly inhibiting
the APC/C already associated with Cdc20 should be the
predominant mechanism of the inhibition of APC/CCdc20.
Mitotic exit switching from APC/CCdc20
to APC/CCdh1
It is accepted that Cdc20 is degraded through APC/CCdh1
ubiquitination at the end of mitosis and thereby APC/CCdc20
is inactivated (37–39). However, details related to this
mechanism regulating the switch from APC/CCdc20 to APC/
CCdh1 are still not entirely clear (5). For example, biochem-
ical analysis has revealed that a considerable amount of
Cdc20 survives this mitotic degradation and enters the next
round of the cell cycle (10,40). Our data demonstrate the
degradation of the Cdc20 not bound to APC/C at the end of
mitosis, indicating that APC/CCdh1 apparently targets only
the APC/C-free Cdc20 at mitotic exit.
Implications for the regulation of APC/CCdc20
in mitosis
The temporal pattern of APC/CCdc20 activity has been well
established (4,5,41) (also shown in Fig. 4 C). APC/CCdc20 is
activated at the onset of prometaphase when it initiates the
degradation of cyclin A (42–44) and Nek2A (45). Its activity
reaches a maximum, plateauing between late prometaphase
and anaphase. Its activity is then gradually reduced, becom-
ing inactivated at the end of mitosis. To this, our data dem-
onstrate the emergence of APC/C-free Cdc20 at the onset of
prometaphase, yielding a maximization quantity during late
prometaphase and metaphase before its disappearance at the
end of mitosis. The presence and the disappearance of this
APC/C-free Cdc20 are closely correlated with the temporal
pattern of the APC/CCdc20 activity in mitosis (Fig. 4, B and
C). This raises the possibility that this APC-free Cdc20 plays
a critical role in the regulation of APC/CCdc20 activity.
A central question in mitosis is whether Cdc20 serves as a
substrate recruiter while being an essential, stoichiometric
component of the APC/C or as a kiss-and-run facilitator that
identiﬁes substrates, brings them back to the APC/C, and
then releases to begin another cycle of substrate binding and
recruitment (13). The concurrence of the appearance of APC/
C-free Cdc20 and the activation of APC/CCdc20 suggests
that, after the rapid phosphorylation and degradation of Emi1
early in mitosis, this small Cdc20 complex is released from
the APC/C for the recruitment of cyclin A for its ubiqui-
tination by APC/C and subsequent degradation.
A second key unresolved issue in mitosis is how APC/
CCdc20 is inactivated for securin and cyclin B recognition by
actively signaling the mitotic checkpoint when all the while
cyclin A is being ubiquitinated. Two competing models have
been proposed, namely, sequestration of Cdc20 and direct
inhibition of Cdc20 already bound to APC/C (10,12,14,15).
Appearance of the small Cdc20 component when the mitotic
checkpoint is maximally active is consistent with the re-
cruiter for substrates to the APC/C, due to the dynamic
interaction. Our data indicate that the small Cdc20 is neither
sequestered from the APC/C nor bound to the APC/C as its
stoichiometric component, even when the mitotic checkpoint
is maximally signaling. Future studies are needed to elu-
cidate the detailed mechanisms of interaction between check-
point proteins. This will require a combination of approaches,
including FCS dual-color cross correlation spectroscopy as
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an essential complement to the more frequently used
methods focused on biochemistry and molecular biology.
The authors thank Dr. Zhongping Chen for his help in developing the FCS
system. Z.W. thanks Dr. C. H. Sun for helpful discussion, L. Li and A.
Stacy for assistance in the experiments, Dr. J. L. Marsh for his help during
the course of this work, and Dr. E. Gratton for providing LFD Global
Unlimited software for PCH data analysis. J.V.S. thanks Drs. Robert Hagan
and Peter Sorger for providing the human Cdc20 cDNA, Frank Furnari for
assistance in developing the retroviral system, and the University of
California, San Diego, Cancer Center Flow Cytometry Facility for cell
sorting.
This work was supported by National Institutes of Health Grant GM66051
(partially to Z.W.), National Institutes of Health Grant RR-14892 and Air
Force Grant F49620 (to M.B.), and National Institutes of Health Grant
GM29513 (to D.W.C.). D.W.C. receives salary support from the Ludwig
Institute for Cancer Research.
REFERENCES
1. Minshull, J., J. J. Blow, and T. Hunt. 1989. Translation of cyclin
messenger-RNA is necessary for extracts of activated xenopus eggs to
enter mitosis. Cell. 56:947–956.
2. Murray, A. W., and M. W. Kirschner. 1989. Cyclin synthesis drives the
early embryonic-cell cycle. Nature. 339:275–280.
3. Page, A. M., and P. Hieter. 1999. The anaphase-promoting complex:
new subunits and regulators. Annu. Rev. Biochem. 68:583–609.
4. Peters, J. M. 2002. The anaphase-promoting complex: proteolysis in
mitosis and beyond. Mol. Cell. 9:931–943.
5. Harper, J. W., J. L. Burton, and M. J. Solomon. 2002. The anaphase-
promoting complex: it’s not just for mitosis any more. Genes Dev.
16:2179–2206.
6. Shah, J. V., and D. W. Cleveland. 2000. Waiting for anaphase: Mad2
and the spindle assembly checkpoint. Cell. 103:997–1000.
7. Glotzer, M., A. W. Murray, and M. W. Kirschner. 1991. Cyclin is
degraded by the ubiquitin pathway. Nature. 349:132–138.
8. Fang, G. W., H. T. Yu, and M. W. Kirschner. 1998. Direct binding of
CDC20 protein family members activates the anaphase-promoting
complex in mitosis and G1. Mol. Cell. 2:163–171.
9. Tang, Z., H. Shu, D. Oncel, S. Chen, and H. Yu. 2004. Phosphoryl-
ation of Cdc20 by Bub1 provides a catalytic mechanism for APC/C
inhibition by the spindle checkpoint. Mol. Cell. 16:387–397.
10. Fang, G. W., H. T. Yu, and M. W. Kirschner. 1998. The checkpoint
protein MAD2 and the mitotic regulator CDC20 form a ternary com-
plex with the anaphase-promoting complex to control anaphase initia-
tion. Genes Dev. 12:1871–1883.
11. Tang, Z. Y., R. Bharadwaj, B. Li, and H. T. Yu. 2001. Mad2-
independent inhibition of APC(Cdc20) by the mitotic checkpoint
protein BubR1. Dev. Cell. 1:227–237.
12. Sudakin, V., G. K. T. Chan, and T. J. Yen. 2001. Checkpoint inhibition
of the APC/C in Hela Cells is mediated by a complex of BURB1,
BUB3, CDC20, and MAD2. J. Cell Biol. 154:925–936.
13. Murray, A. W. 2004. Recycling the cell cycle: cyclins revisited. Cell.
116:221–234.
14. Chen, R. H., A. Shevchenko, M. Mann, and A. W. Murray. 1998.
Spindle checkpoint protein Xmad1 recruits Xmad2 to unattached
kinetochores. J. Cell Biol. 143:283–295.
15. Chan, G. K., and T. J. Yen. 2003. The mitotic checkpoint: a signaling
pathway that allows a single unattached kinetochore to inhibit mitotic
exit. In Progress in Cell Cycle Research. L. Meijer, A. Jezequel, and M.
Roberge, editors. Springer, New York. 431–439.
16. Reimann, J. D. R., E. Freed, J. Y. Hsu, E. R. Kramer, J. M. Peters, and
P. K. Jackson. 2001. Emi1 is a mitotic regulator that interacts with
Cdc20 and inhibits the anaphase promoting complex. Cell. 105:
645–655.
17. Hsu, J. Y., J. D. R. Reimann, C. S. Sorensen, J. Lukas, and P. K.
Jackson. 2002. E2F-dependent accumulation of hEmi1 regulates S
phase entry by inhibiting APC(Cdh1). Nat. Cell Biol. 4:358–366.
18. Yu, H. T. 2002. Regulation of APC-Cdc20 by the spindle checkpoint.
Curr. Opin. Cell Biol. 14:706–714.
19. Elson, E. L., and D. Magde. 1974. Fluorescence correlation spectros-
copy. 1. Conceptual basis and theory. Biopolymers. 13:1–27.
20. Magde, D., W. W. Webb, and E. Elson. 1972. Thermodynamic
ﬂuctuations in a reacting system—measurement by ﬂuorescence corre-
lation spectroscopy. Phys. Rev. Lett. 29:705–708.
21. Berland, K. M., P. T. C. So, and E. Gratton. 1995. 2-Photon
ﬂuorescence correlation spectroscopy—method and application to the
intracellular environment. Biophys. J. 68:694–701.
22. Brock, R., M. A. Hink, and T. M. Jovin. 1998. Fluorescence correlation
microscopy of cells in the presence of autoﬂuorescence. Biophys. J.
75:2547–2557.
23. Schwille, P., U. Haupts, S. Maiti, and W. W. Webb. 1999. Molecular
dynamics in living cells observed by ﬂuorescence correlation spec-
troscopy with one- and two-photon excitation. Biophys. J. 77:2251–
2265.
24. Chen, Y., J. D. Muller, Q. Q. Ruan, and E. Gratton. 2002. Molecular
brightness characterization of EGFP in vivo by ﬂuorescence ﬂuctuation
spectroscopy. Biophys. J. 82:133–144.
25. Kohler, R. H., P. Schwille, W. W. Webb, and M. R. Hanson. 2000.
Active protein transport through plastid tubules: velocity quantiﬁed by
ﬂuorescence correlation spectroscopy. J. Cell Sci. 113:3921–3930.
26. Wang, Z., J. V. Shah, Z. Chen, C. H. Sun, and M. W. Berns. 2004.
Fluorescence correlation spectroscopy investigation of a GFP mutant-
enhanced cyan ﬂuorescent protein and its tubulin fusion in living cells
with two-photon excitation. J. Biomed. Opt. 9:395–403.
27. Larson, D. R., Y. M. Ma, V. M. Vogt, and W. W. Webb. 2003. Direct
measurement of Gag-Gag interaction during retrovirus assembly with
FRET and ﬂuorescence correlation spectroscopy. J. Cell Biol. 162:
1233–1244.
28. Shah, J. V., E. Botvinick, Z. Bonday, F. Furnari, M. Berns, and D. W.
Cleveland. 2004. Dynamics of centromere and kinetochore proteins;
implications for checkpoint signaling and silencing. Curr. Biol. 14:
942–952.
29. Thompson, N. L. 1991. Fluorescence correlation spectroscopy. In
Topics in Fluorescence Spectroscopy. J. R. Lakowicz, editor. Plenum,
New York. 337–378.
30. Hess, S. T., S. H. Huang, A. A. Heikal, and W. W. Webb. 2002. Bio-
logical and chemical applications of ﬂuorescence correlation spectros-
copy: a review. Biochemistry. 41:697–705.
31. Chen, Y., J. D. Muller, K. M. Berland, and E. Gratton. 1999.
Fluorescence ﬂuctuation spectroscopy. Methods. 19:234–252.
32. Meseth, U., T. Wohland, R. Rigler, and H. Vogel. 1999. Resolution of
ﬂuorescence correlation measurements. Biophys. J. 76:1619–1631.
33. Kallio, M. J., V. A. Beardmore, J. Weinstein, and G. J. Gorbsky. 2002.
Rapid microtubule-independent dynamics of Cdc20 at kinetochores
and centrosomes in mammalian cells. J. Cell Biol. 158:841–847.
34. Howell, B. J., B. Moree, E. M. Farrar, S. Stewart, G. Fang, and E. D.
Salmon. 2004. Spindle checkpoint protein dynamics at kinetochores in
living cells. Curr. Biol. 14:953–964.
35. Dong, X. Z., K. H. Zavitz, B. J. Thomas, M. Lin, S. Campbell, and
S. L. Zipursky. 1997. Control of G1 in the developing Drosophila eye:
rca1 regulates Cyclin A. Genes Dev. 11:94–105.
36. Reimann, J. D. R., B. E. Gardner, F. Margottin-Goguet, and P. K.
Jackson. 2001. Emi1 regulates the anaphase-promoting complex
by a different mechanism than Mad2 proteins. Genes Dev. 15:3278–
3285.
37. Pﬂeger, C. M., and M. W. Kirschner. 2000. The KEN box: an APC
recognition signal distinct from the D box targeted by Cdh1. Genes
Dev. 14:655–665.
350 Wang et al.
Biophysical Journal 91(1) 343–351
38. Prinz, S., E. S. Hwang, R. Visintin, and A. Amon. 1998. The regula-
tion of Cdc20 proteolysis reveals a role for the APC components
Cdc23 and Cdc27 during S phase and early mitosis. Curr. Biol. 8:
750–760.
39. Shirayama, M., W. Zachariae, R. Ciosk, and K. Nasmyth. 1998. The
polo-like kinase Cdc5p and the WD-repeat protein Cdc2Op/ﬁzzy are
regulators and substrates of the anaphase promoting complex in
Saccharomyces cerevisiae. EMBO J. 17:1336–1349.
40. Zhang, Y. K., and E. Lees. 2001. Identiﬁcation of an overlapping
binding domain on Cdc20 for Mad2 and anaphase-promoting complex:
model for spindle checkpoint regulation. Mol. Cell. Biol. 21:
5190–5199.
41. Zachariae, W., and K. Nasmyth. 1999. Whose end is destruction:
cell division and the anaphase-promoting complex. Genes Dev. 13:
2039–2058.
42. den Elzen, N., and J. Pines. 2001. Cyclin a is destroyed in
prometaphase and can delay chromosome alignment and anaphase.
J. Cell Biol. 153:121–135.
43. Geley, S., E. Kramer, C. Gieffers, J. Gannon, J. M. Peters, and T. Hunt.
2001. Anaphase-promoting complex/cyclosome-dependent proteolysis
of human cyclin a starts at the beginning of mitosis and is not subject to
the spindle assembly checkpoint. J. Cell Biol. 153:137–147.
44. Dawson, I. A., S. Roth, and S. Artavanistsakonas. 1995. The
Drosophila cell cycle gene ﬁzzy is required for normal degradation
of cyclins A and B during mitosis and has homology to the CDC20
gene of Saccharomyces-cerevisiae. J. Cell Biol. 129:725–737.
45. Hames, R. S., S. L. Wattam, H. Yamano, R. Bacchieri, and A. M. Fry.
2001. APC/C-mediated destruction of the centrosomal kinase Nek2A
occurs in early mitosis and depends upon a cyclin A-type D-box.
EMBO J. 20:7117–7127.
FCS Studies of Cdc20 351
Biophysical Journal 91(1) 343–351
